Xiang Kong

1.1k total citations
32 papers, 859 citations indexed

About

Xiang Kong is a scholar working on Molecular Biology, Plant Science and Cancer Research. According to data from OpenAlex, Xiang Kong has authored 32 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Plant Science and 7 papers in Cancer Research. Recurrent topics in Xiang Kong's work include Sesame and Sesamin Research (10 papers), RNA modifications and cancer (6 papers) and Neurological Disease Mechanisms and Treatments (5 papers). Xiang Kong is often cited by papers focused on Sesame and Sesamin Research (10 papers), RNA modifications and cancer (6 papers) and Neurological Disease Mechanisms and Treatments (5 papers). Xiang Kong collaborates with scholars based in China, United States and Puerto Rico. Xiang Kong's co-authors include Yang Jie-ren, Mingzhe Weng, Zhiwei Quan, Mingzhe Ma, Wei Gong, Kun Lv, Qiang Hua, Junxiu Zhang, Yiyu Qin and Liqun Guo and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical Pharmacology.

In The Last Decade

Xiang Kong

31 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiang Kong China 19 430 282 161 108 107 32 859
Hongxia Yang China 20 450 1.0× 144 0.5× 102 0.6× 61 0.6× 69 0.6× 55 988
Manyu Luo China 19 508 1.2× 142 0.5× 121 0.8× 71 0.7× 74 0.7× 43 1.0k
Randa H. Mohamed Egypt 17 216 0.5× 108 0.4× 74 0.5× 94 0.9× 56 0.5× 42 732
Sebastián D. Calligaris Chile 14 433 1.0× 92 0.3× 105 0.7× 69 0.6× 112 1.0× 23 831
Hossein Babaahmadi‐Rezaei Iran 17 425 1.0× 108 0.4× 77 0.5× 63 0.6× 59 0.6× 57 919
Minglu Liang China 20 441 1.0× 185 0.7× 98 0.6× 62 0.6× 128 1.2× 52 884
Varvara A. Orekhova Russia 13 337 0.8× 96 0.3× 97 0.6× 56 0.5× 89 0.8× 32 791

Countries citing papers authored by Xiang Kong

Since Specialization
Citations

This map shows the geographic impact of Xiang Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Kong more than expected).

Fields of papers citing papers by Xiang Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Kong. The network helps show where Xiang Kong may publish in the future.

Co-authorship network of co-authors of Xiang Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang Kong. A scholar is included among the top collaborators of Xiang Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang Kong. Xiang Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yan, Zhi-yuan Chen, Kai Li, et al.. (2025). β-Hydroxybutyrate ameliorates lipopolysaccharide-induced liver injury through β-hydroxybutyrylation of the SOD2 protein in mice. Redox Biology. 88. 103949–103949.
2.
Xing, Yujie, Tao Ma, Kai Li, et al.. (2024). β-Hydroxybutyrate suppresses M1 macrophage polarization through β-hydroxybutyrylation of the STAT1 protein. Cell Death and Disease. 15(12). 874–874. 13 indexed citations
3.
Zhang, Teng, Zhengyan Hu, Yan Zhang, et al.. (2024). Sesamin ameliorates nonalcoholic hepatic steatosis by inhibiting CD36-mediated hepatocyte lipid accumulation in vitro and in vivo. Biochemical Pharmacology. 224. 116240–116240. 9 indexed citations
4.
Sun, Yue, Liqun Guo, Deguo Wang, et al.. (2023). Metformin alleviates glucolipotoxicity-induced pancreatic β cell ferroptosis through regulation of the GPX4/ACSL4 axis. European Journal of Pharmacology. 956. 175967–175967. 22 indexed citations
5.
Wan, Shujun, Qiang Hua, Yujie Xing, et al.. (2022). Decreased Urine N6-methyladenosine level is closely associated with the presence of diabetic nephropathy in type 2 diabetes mellitus. Frontiers in Endocrinology. 13. 986419–986419. 8 indexed citations
6.
Zhou, Simin, Yue Sun, Yujie Xing, et al.. (2022). Exenatide ameliorates hydrogen peroxide-induced pancreatic β-cell apoptosis through regulation of METTL3-mediated m6A methylation. European Journal of Pharmacology. 924. 174960–174960. 22 indexed citations
7.
Xing, Yujie, Shujun Wan, Yi Cheng, et al.. (2021). A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro. Frontiers in Pharmacology. 12. 708177–708177. 56 indexed citations
8.
Ramirez‐Fort, Marigdalia K., Marc J. Rogers, Sean S. Mahase, et al.. (2020). Prostatic irradiation-induced sexual dysfunction: a review and multidisciplinary guide to management in the radical radiotherapy era (Part I defining the organ at risk for sexual toxicities). Reports of Practical Oncology & Radiotherapy. 25(3). 367–375. 17 indexed citations
9.
Kong, Xiang, Ailing Lu, Qiang Hua, et al.. (2017). Activation of NLRP3 Inflammasome by Advanced Glycation End Products Promotes Pancreatic Islet Damage. Oxidative Medicine and Cellular Longevity. 2017(1). 9692546–9692546. 48 indexed citations
10.
Ma, Mingzhe, Yan Zhang, Mingzhe Weng, et al.. (2016). Long Noncoding RNA GCASPC , a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase–Dependent Cell Proliferation in Gallbladder Cancer. Cancer Research. 76(18). 5361–5371. 77 indexed citations
11.
Qi, Jun, Tao Huang, Xin Gu, et al.. (2015). Pirfenidone attenuates bladder fibrosis and mitigates deterioration of bladder function in a rat model of partial bladder outlet obstruction. Molecular Medicine Reports. 12(3). 3639–3647. 13 indexed citations
12.
Zheng, Shuguo, et al.. (2015). [Effect of Serum Containing Sesamin on Angiotensin II-Induced Apoptosis in Rat Cardiomyocytes].. PubMed. 38(5). 1013–7. 2 indexed citations
13.
14.
Ma, Mingzhe, Xiang Kong, Mingzhe Weng, et al.. (2014). Long non‐coding RNA‐LET is a positive prognostic factor and exhibits tumor‐suppressive activity in gallbladder cancer. Molecular Carcinogenesis. 54(11). 1397–1406. 60 indexed citations
15.
16.
Kong, Xiang, Mingzhe Ma, Yan Zhang, et al.. (2014). Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma. BMC Complementary and Alternative Medicine. 14(1). 254–254. 30 indexed citations
17.
Kong, Xiang, Mingzhe Ma, Li Qin, et al.. (2013). Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction. Journal of the Renin-Angiotensin-Aldosterone System. 15(3). 259–270. 16 indexed citations
18.
Kong, Xiang. (2012). Protective effect of Sesamin on endothelial function of type-2 diabetic rats. Zhongguo yaolixue tongbao. 3 indexed citations
19.
Li, Wenxing, Xiang Kong, Junxiu Zhang, & Yang Jie-ren. (2012). Long-term intake of sesamin improves left ventricular remodelling in spontaneously hypertensive rats. Food & Function. 4(3). 453–460. 21 indexed citations
20.
Kong, Xiang, Yang Jie-ren, Liqun Guo, et al.. (2009). Sesamin improves endothelial dysfunction in renovascular hypertensive rats fed with a high-fat, high-sucrose diet. European Journal of Pharmacology. 620(1-3). 84–89. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongxia Yang Breakdown of academic impact, for papers by Manyu Luo Breakdown of academic impact, for papers by Randa H. Mohamed Breakdown of academic impact, for papers by Sebastián D. Calligaris Breakdown of academic impact, for papers by Hossein Babaahmadi‐Rezaei Breakdown of academic impact, for papers by Minglu Liang Breakdown of academic impact, for papers by Varvara A. Orekhova
Rankless by CCL
2026